Roche Holding AG (RHHBF)

USD 303.32

(0.0%)

Total Assets Summary of Roche Holding AG

  • Roche Holding AG's latest annual total assets in 2023 was 90.46 Billion CHF , up 2.63% from previous year.
  • Roche Holding AG's latest quarterly total assets in 2024 Q1 was 95.78 Billion CHF , up 5.88% from previous quarter.
  • Roche Holding AG reported annual total assets of 88.15 Billion CHF in 2022, down -4.51% from previous year.
  • Roche Holding AG reported annual total assets of 92.31 Billion CHF in 2021, up 7.17% from previous year.
  • Roche Holding AG reported quarterly total assets of 95.78 Billion CHF for 2024 Q1, up 5.88% from previous quarter.
  • Roche Holding AG reported quarterly total assets of 84.37 Billion CHF for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Roche Holding AG (2023 - 1998)

Historical Annual Total Assets of Roche Holding AG (2023 - 1998)

Year Total Assets Total Assets Growth
2023 90.46 Billion CHF 2.63%
2022 88.15 Billion CHF -4.51%
2021 92.31 Billion CHF 7.17%
2020 86.13 Billion CHF 3.67%
2019 83.09 Billion CHF 5.83%
2018 78.51 Billion CHF 2.4%
2017 76.67 Billion CHF -0.19%
2016 76.81 Billion CHF 1.39%
2015 75.76 Billion CHF 0.16%
2014 75.64 Billion CHF 21.67%
2013 62.16 Billion CHF -4.07%
2012 64.8 Billion CHF 5.24%
2011 61.57 Billion CHF 0.91%
2010 61.02 Billion CHF -18.17%
2009 74.56 Billion CHF -2.0%
2008 76.08 Billion CHF -2.68%
2007 78.18 Billion CHF 5.06%
2006 74.41 Billion CHF 7.28%
2005 69.36 Billion CHF 19.44%
2004 58.07 Billion CHF -2.37%
2003 59.48 Billion CHF -7.05%
2002 63.99 Billion CHF -15.0%
2001 75.28 Billion CHF 8.27%
2000 69.53 Billion CHF -1.27%
1999 70.43 Billion CHF 26.04%
1998 55.87 Billion CHF 0.0%

Peer Total Assets Comparison of Roche Holding AG

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD 10.407%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD 4.93%
CSPC Pharmaceutical Group Limited 6.52 Billion USD -1286.692%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -174859.387%
Novartis AG 99.94 Billion USD 9.482%
PT Kalbe Farma Tbk. 1.75 Billion USD -5043.904%